-
11.
公开(公告)号:US20090047716A1
公开(公告)日:2009-02-19
申请号:US12135847
申请日:2008-06-09
Applicant: Nurit PERLMAN , Ayelet Fishman
Inventor: Nurit PERLMAN , Ayelet Fishman
IPC: C12P17/10 , C07D205/08
CPC classification number: C12P17/10
Abstract: Processes for preparing ezetimibe-related compounds with a ketoreductase and for purifying ezetimibe are disclosed.
Abstract translation: 公开了用酮还原酶制备依泽替米贝相关化合物和纯化依泽替米贝的方法。
-
12.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
Title translation: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US20080146817A1
公开(公告)日:2008-06-19
申请号:US11699659
申请日:2007-01-29
Applicant: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
Inventor: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
IPC: C07D209/04
CPC classification number: C07D209/12 , C07D209/24
Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
Abstract translation: 提供氟伐他汀钠的结晶形式及其制备方法。
-
13.Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them 失效
Title translation: 氟伐他汀钠晶体形成XIV,LXXIII,LXXIX,LXXX和LXXXVII,制备它们的方法,含有它们的组合物和使用它们的方法公开(公告)号:US07368468B2
公开(公告)日:2008-05-06
申请号:US10871916
申请日:2004-06-18
Applicant: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman
Inventor: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman
IPC: A61K31/40 , C07D209/12
CPC classification number: C07D209/24
Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
Abstract translation: 提供氟伐他汀钠的多晶型物质及其制备方法。
-
14.Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them 失效
Title translation: 氟伐他汀钠晶体形成XIV,LXXIII,LXXIX,LXXX和LXXXVII,制备它们的方法,含有它们的组合物和使用它们的方法公开(公告)号:US20050038114A1
公开(公告)日:2005-02-17
申请号:US10871916
申请日:2004-06-18
Applicant: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman
Inventor: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman
IPC: C07D209/24 , C07C69/66 , A61K31/225
CPC classification number: C07D209/24
Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
Abstract translation: 提供氟伐他汀钠的多晶型物质及其制备方法。
-
15.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
Title translation: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US07687642B2
公开(公告)日:2010-03-30
申请号:US11699659
申请日:2007-01-29
Applicant: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
Inventor: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
IPC: C07D209/12
CPC classification number: C07D209/12 , C07D209/24
Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
Abstract translation: 提供氟伐他汀钠的结晶形式及其制备方法。
-
16.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 审中-公开
Title translation: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US20090118518A1
公开(公告)日:2009-05-07
申请号:US12150949
申请日:2008-04-30
Applicant: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
Inventor: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
IPC: C07D209/04
CPC classification number: C07D209/12 , C07D209/24
Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
Abstract translation: 提供氟伐他汀钠的结晶形式及其制备方法。
-
17.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
Title translation: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US07414140B2
公开(公告)日:2008-08-19
申请号:US10872089
申请日:2004-06-18
Applicant: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
Inventor: Revital Lifshitz-Liron , Tamas Koltai , Judith Aronhime , Nurit Perlman , Sharon Avhar-Maydan
IPC: C07D209/12
CPC classification number: C07D209/12 , C07D209/24
Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
Abstract translation: 提供氟伐他汀钠的多晶型物质及其制备方法。
-
公开(公告)号:US20080114171A1
公开(公告)日:2008-05-15
申请号:US11890316
申请日:2007-08-03
Applicant: Tamas Koltai , Nurit Perlman , Tamar Nidam , Mili Abramov
Inventor: Tamas Koltai , Nurit Perlman , Tamar Nidam , Mili Abramov
IPC: C07D453/02 , A61P13/10
CPC classification number: C07D453/02 , C07D217/02
Abstract: Polymorphic forms of solifenacin base have been prepared and characterized. These polymorphic forms are particularly useful for preparing solifenacin salts.
Abstract translation: 已经制备和表征索非那新碱的多晶型。 这些多晶型对于制备索非那新盐特别有用。
-
公开(公告)号:US20080114029A1
公开(公告)日:2008-05-15
申请号:US11890264
申请日:2007-08-03
Applicant: Tamas Koltai , Nurit Perlman , Tamar Nidam , Dov Diller
Inventor: Tamas Koltai , Nurit Perlman , Tamar Nidam , Dov Diller
IPC: A61K31/47 , C07D217/02
CPC classification number: C07D453/02 , C07D217/02
Abstract: Polymorphic forms of 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline have been prepared and characterized. These polymorphic forms are particularly useful for preparing solifenacin salts.
Abstract translation: 已经制备并表征了1(S) - 苯基-1,2,3,4-四氢异喹啉的多晶型。 这些多晶型对于制备索非那新盐特别有用。
-
20.Process for preparing polymorphic forms of solifenacin succinate 审中-公开
Title translation: 制备solifenacin琥珀酸多晶型物的方法公开(公告)号:US20080114028A1
公开(公告)日:2008-05-15
申请号:US11881161
申请日:2007-07-24
Applicant: Tamas Koltai , Tamar Nidam , Eyal Gilboa , Nurit Perlman , Michael Pinhasov , Mili Abramov
Inventor: Tamas Koltai , Tamar Nidam , Eyal Gilboa , Nurit Perlman , Michael Pinhasov , Mili Abramov
IPC: A61K31/4745 , C07D453/02
CPC classification number: C07D453/02
Abstract: Polymorphic forms of solifenacin have been prepared and characterized. These polymorphic forms are particularly useful in pharmaceutical compositions.
Abstract translation: 已经制备和表征索非那新的多晶型形式。 这些多晶型在药物组合物中特别有用。
-
-
-
-
-
-
-
-
-